Digestives & Intestinal Remedies - Ukraine

In Ukraine, the Digestives & Intestinal Remedies market market generates a revenue of US$285.60m in 2024.
It is projected to experience an annual growth rate of 2.08% (CAGR 2024-2029).
When compared globally, China generates the highest revenue in this market, reaching US$4.41bn in 2024.
In terms of per capita revenue, each person in Ukraine contributes US$7.53 units in 2024.
Ukraine's Digestives & Intestinal Remedies market is witnessing a surge in demand for natural and herbal remedies.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestives & Intestinal Remedies market in Ukraine has experienced steady growth in recent years, driven by changing customer preferences and trends in the market. Customer preferences in the Digestives & Intestinal Remedies market in Ukraine have shifted towards natural and herbal remedies, as consumers are increasingly seeking products that are perceived as healthier and more sustainable. This trend is in line with global market trends, where there is a growing demand for natural and organic products. In addition, there is a rising awareness among consumers about the importance of gut health and its impact on overall well-being, which has led to an increased interest in Digestives & Intestinal Remedies.The market is also witnessing a shift towards online retail channels, as more consumers in Ukraine are embracing e-commerce for their shopping needs. This trend is driven by the convenience and wide range of products available online, as well as the increasing penetration of smartphones and internet access in the country. Online platforms offer a convenient way for consumers to compare prices and read reviews before making a purchase, which has contributed to the growth of the Digestives & Intestinal Remedies market in Ukraine.Local special circumstances in Ukraine have also played a role in the development of the Digestives & Intestinal Remedies market. The country has a rich tradition of herbal medicine, with many Ukrainians relying on traditional remedies for digestive health. This cultural heritage has influenced consumer preferences and has contributed to the demand for natural and herbal Digestives & Intestinal Remedies in the market.Underlying macroeconomic factors have also had an impact on the Digestives & Intestinal Remedies market in Ukraine. The country has experienced economic growth in recent years, which has led to an increase in disposable income and consumer spending. As a result, consumers in Ukraine have more purchasing power and are willing to spend on health and wellness products, including Digestives & Intestinal Remedies.In conclusion, the Digestives & Intestinal Remedies market in Ukraine is developing in response to changing customer preferences towards natural and herbal remedies, the shift towards online retail channels, local cultural influences, and underlying macroeconomic factors. As consumer awareness about gut health continues to grow and the demand for natural and organic products increases, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.